Pharmacovigilance has advanced in detecting population-level safety signals, but a critical gap remains in translating those insights into transparent, defensible patient-level decisions.
Eytan Ellenberg, MD, MPH, PhD
Advertisement
Articles by Eytan Ellenberg, MD, MPH, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verana Health Merges With COTA to Expand Real-World Data Capabilities Across Oncology and Specialty Care
2
Why Trial Competition Is Undermining AI-Driven Gains
3
ACT Brief: Recalibrating Trial Efficiency and Access, Verana-COTA Merge to Expand RWE Scale, and FDA Rejects Hetlioz Jet Lag Indication
4
Reasoning About Individual Drug Causality in a Multifactorial World
5